2019 Pharma Choice Multicultural Bronze Winner EMCAY and Amgen Inc.

EMCAY

Amgen Inc.

Multiple Myeloma It’s On

Multiple myeloma is the second most common blood cancer in the United States, but is the most common blood cancer among African Americans. With the introduction of newer therapies, African Americans have benefited less. This truly unique creative campaign helps to address some of the key issues facing the community.

Client Team:

Michelle Kelly, Consumer Marketing Senior Manager, Oncology

Ads

You May Also Like

PM360 2018 Innovative Product Edge Trial Assurance from Medidata

Edge Trial Assurance Medidata Erik Snider, Senior Director of Corporate Communications esnider@mdsol.com Nearly 50% ...

PM360 2018 Trailblazer Awards Consumer Website/Online Initiative Winner Avanos and AbelsonTaylor

COOLIEF Website www.mycoolief.com (Avanos, AbelsonTaylor) Over 30 million Americans suffer from osteoarthritis, with the ...

PM360 2019 Trailblazer Awards Diversity/Multicultural Brand Champion Elizabeth Rosato

Elizabeth Rosato, Repatha Consumer Marketing, Amgen The Repatha Hispanic market campaign is reaching new ...